Production-linked incentive schemes should also focus on companies providing packaging materials and other services in addition to manufacturers of branded pharmaceutical items to reduce import dependence, according to Bharat Biotech Executive Director Sai Prasad.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/s5nV71o
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» PLI schemes should also focus on entities supporting production of branded pharma products: Bharat Biotech
0 comments:
Post a Comment